Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration for its use ...
In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...
Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...
Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses small, targeted amounts of steam to kill cancer cells is a safe and effective ...
Hosted on MSN1d
Laparoscopic Radical Prostatectomy in NigeriaEleos Specialist Hospital has commenced laparoscopic radical prostatectomy (also known as keyhole Surgery for Prostate Cancer ...
Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback